Finite-Blocklength Results for the A-channel: Applications to Unsourced Random Access and Group Testing
Alejandro Lancho, Alexander Fengler, Yury Polyanskiy

TL;DR
This paper derives finite-blocklength bounds for the A-channel, demonstrating its applications in unsourced random access and group testing, and proposing improved decoding and testing matrix constructions.
Contribution
It introduces finite-blocklength achievability bounds for the A-channel and connects these results to enhanced group testing and random access methods.
Findings
Achieves bounds for error probabilities in group testing with A-channel codes.
Provides constructions of group testing matrices with sub-linear decoding time.
Shows asymptotic optimality in the number of tests for certain group testing scenarios.
Abstract
We present finite-blocklength achievability bounds for the unsourced A-channel. In this multiple-access channel, users noiselessly transmit codewords picked from a common codebook with entries generated from a -ary alphabet. At each channel use, the receiver observes the set of different transmitted symbols but not their multiplicity. We show that the A-channel finds applications in unsourced random-access (URA) and group testing. Leveraging the insights provided by the finite-blocklength bounds and the connection between URA and non-adaptive group testing through the A-channel, we propose improved decoding methods for state-of-the-art A-channel codes and we showcase how A-channel codes provide a new class of structured group testing matrices. The developed bounds allow to evaluate the achievable error probabilities of group testing matrices based on random A-channel codes for…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 detection and testing · Advanced biosensing and bioanalysis techniques · Immunodeficiency and Autoimmune Disorders
